イソステリック3Dビシクロ[1.1.1]ペンタン (BCP) コアベースの脂質mRNA配送とCRISPR/Cas遺伝子編集
Shiying Wu1, Yangyang Yang1, Xizhen Lian1
1Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas 75390, United States.
Journal of the American Chemical Society
|December 10, 2024
まとめ
研究者は,強化されたメッセンジャーRNA (mRNA) 配送のために,ビサイクロ[1.1.1]ペンタン (BCP) コアを使用して,新しい3次元 (3D) のイオン化脂質を開発した. これらの3D脂質は,従来の2D設計と比較して,in vivo mRNAおよび遺伝子編集の治療効率を大幅に改善しました.
科学分野:
- 生物化学
- 材料科学
- 医薬品科学
背景:
- 脂質ナノ粒子 (LNP) は,mRNAワクチンおよび遺伝子編集療法において極めて重要です.
- 現在の電離性アミノリピッドは2D構造に限定されており,発送効率を阻害する可能性がある.
- 三次元 (3D) 薬物アーキテクチャは,物理化学的特性を改善することができます.
研究 の 目的:
- ビサイクロ[1.1.1]ペンタン (BCP) コアモチーフを使用して,新しい3Dイオン化アミノリピドを設計および合成する.
- mRNA配送と遺伝子編集におけるBCPベースのLNPのインビボ性能を評価する.
- 3D BCP ベースの脂質の有効性を2D アナログと臨床的に使用される LNP と比較する.
主な方法:
- BCPコア構造を含む3Dイオン化脂質の合成
- BCPベースの脂質を使用したLNPの製剤.
- 肝臓と臓へのLNP媒介 mRNAのインビボ評価
- CRISPR/Cas9によるPCSK9を標的とした遺伝子編集の効率の評価
主要な成果:
- BCPベースの脂質は,肝臓と臓への効率的なmRNA配送を in vivoで実証した.
- 3D BCPベースのLNPは,2Dベンゼンとサイクロヘキサンベースの類似体を大幅に上回りました.
- 鉛のBCP-NC2-C12LNPは,CRISPR/Cas9遺伝子のノックアウトによって約90%のPCSK9減少を達成し,2D対照群とDLin-MC3-DMALNPを上回った.
- この研究は,インビボ活性が強化された優れた3Dイオン化脂質設計を導入します.
結論:
- 3D BCP コアモチーフの導入は,電離性アミノ脂質の化学的多様性を拡大する.
- BCPベースのLNPは,mRNAと遺伝子編集の配信効率を改善するための有望な進歩を表しています.
- この研究は 次世代の遺伝薬の開発に 新たな道を開きます
関連する概念動画
CRISPR and crRNAs
16.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.7K
CRISPR
49.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.4K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K


